SHANGHAI--(BUSINESS WIRE)--YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene editing therapies, today announced positive interim data from an ...

The objective of this project is to build and compare multiple machine learning classification models to predict wine quality. The task involves classifying wines into two categories: Good Quality ...

Evommune has aced its first major test as a public company, reporting phase 2a eczema data that caused its share price to jump 75% in premarket trading. The biotech, which went public late last year, ...

Every warfighting function depends on logistics, but sustainment has always faced a time-distance problem. Commanders maneuver in hours while logisticians plan in days. By the time a logistics ...

Abstract: Data augmentation is crucial for addressing insufficient training data, especially for augmenting positive samples. However, existing methods mostly rely on neural network-based feedback for ...

Study met its primary endpoint demonstrating safety and tolerability of CMTX-101 in people with cystic fibrosis CMTX-101 treatment produced clinically meaningful reductions in key inflammatory ...

Faculty develop methods for structured and unstructured biomedical data that advance statistical inference, machine learning, causal inference, and algorithmic modeling. Their work delivers principled ...

The investment seeks long-term growth of capital by investing primarily in securities of companies that meet the fund's environmental, social and governance (ESG) criteria. To pursue its goal, the ...

The last time I wrote about Kyverna Therapeutics (KYTX) it was with respect to a Seeking Alpha article entitled "Kyverna: 2 Myasthenia Gravis Program Catalysts On Deck In 2025". With respect to this ...

As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, a much smaller potential rival ...

Abstract: This paper addresses the problem of input-output data-based ultimate boundedness control for a class of networked systems subject to probabilistic bit flips and false data injection (FDI) ...

Nearly all (90%) of essential thrombocythemia (ET) patients treated with INCA033989 at the higher dose achieved a hematologic response (HR) with 83.3% achieving a complete HR Molecular responses were ...